Should You Buy, Sell or Hold Marsh & McLennan Stock at a 7.47X P/B?

Marsh & McLennan Companies, Inc. (MMC) , operating in the insurance brokerage space, is currently considered relatively overvalued, trading at a trailing 12-month price/book (P/B) of 7.47X. This figure is higher than the broader Insurance- Brokerage average of 6.72X. Other industry players, such as Arthur J. Gallagher & Co. (AJG) and Brown & Brown, Inc. (BRO) , are trading at 5.74X and 4.48X P/B, respectively. Given MMC’s premium valuation, we need to carefully assess this stock’s key drivers and growth pro ...